Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-061235·CITADEL ADVISORS LLC
Schedule 13G ownership disclosure
Cabaletta Bio Inc
Common stock, par value $0.00001 per share (the "Shares") · CUSIP: 12674W109
Event date: 2025-06-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Citadel Advisors LLC
Shares: 4,687,280.00 · Class: 5.0%
- Citadel Advisors Holdings LP
Shares: 4,687,280.00 · Class: 5.0%
- Citadel GP LLC
Shares: 4,687,280.00 · Class: 5.0%
- Citadel Securities LLC
Shares: 131,280.00 · Class: 0.1%
- Citadel Securities Group LP
Shares: 131,280.00 · Class: 0.1%
- Citadel Securities GP LLC
Shares: 131,280.00 · Class: 0.1%
- Kenneth Griffin
Shares: 4,818,560.00 · Class: 5.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-061235
- Form type
- SCHEDULE 13G
- Filer
- CITADEL ADVISORS LLC
- CIK
- CIK 1423053
- Filed
- Jun 20, 2025
- Reporting period
- Jun 12, 2025
- Description
- Schedule 13G beneficial ownership